He is a Professor in the Department of Radiation Oncology at the University of Toronto, and was the first Chair of that department from to His clinical and research interests are in gastrointestinal cancers, particularly rectal and anal cancers, and in head and neck cancers. He is active in organizing and participating in teaching programs in radiation oncology in developing countries. He has been an advisor to the World Health Organization on patient safety in radiation therapy, and to the International Atomic Energy Agency on radiation therapy for rectal cancer in developing countries.
Robert Califf leads a multifaceted organization focused on the transformation of how discoveries are translated into improved health outcomes. He is the editor-in-chief of American Heart Journal, the oldest cardiovascular specialty journal.
Califf completed his undergraduate studies at Duke University in , summa cum laude and Phi Beta Kappa. After completing internship and internal medicine residency at the University of California, San Francisco, he returned to Duke for a fellowship in cardiology. Califf led many landmark clinical trials in cardiovascular disease.
A leader in clinical research, DCRI collaborates extensively with government agencies, global academic partners, foundations and biotech, pharmaceutical, device, and diagnostics companies to execute clinical trials in a myriad of therapeutic arenas. He remains actively involved in the leadership, design, and execution of multinational clinical trials. Califf currently serves as the co-chair of the Clinical Trials Transformation Initiative, a public private partnership focused on improving the clinical trials system, and as the Chair of the Clinical Research Forum, an organization of academic health and science system leaders focused on the improvement of the clinical research enterprise.
Elizabeth Eisenhauer. Through her work in the IND Program, she directed the coordination of over phase I, II and III trials across Canada, the US and Europe, which included some of the first trials of paclitaxel and docetaxel, studies of topotecan, gemcitabine, various targeted antisense agents, angiogenesis inhibitors, and small molecule signaling inhibitors.
She has also received numerous awards including, in , the O. That same year, Dr.
- Browse by All Cardiff Authors!
- The Structural Econometric Time Series Analysis Approach.
- You may also be interested in...?
- You may also be interested in....
- Peggy Guggenheim: The Life of an Art Addict (Text Only)!
- ESMO Handbooks | Medical Oncology Education | OncologyPRO.
Ian Tannock. Whither or Wither? His clinical research investigates methods related to cancer clinical trials, and he chaired trials for men with metastatic prostate cancer that led to licensing of previous mitoxantrone and current docetaxel standard chemotherapy.
ESMO Handbook of Cancer in the Senior Patient - Google книги
His laboratory research evaluates effects of the tumour microenvironment on outcome of cancer therapy. He is an editor of the Basic Science of Oncology textbook, now in its 5th edition, that is used by trainees in all branches of oncology. He received the alumnus award from M. Tannock was appointed a Member of the Order of Canada in December Joseph M.
He obtained his medical degree at Yale University, trained in internal medicine at the University of North Carolina in Chapel Hill, and completed his medical oncology fellowship at the Stanford University Medical Center. While at the BC Cancer Agency and University of British Columbia, he has focused his clinical activities and research efforts in the area of lymphoid cancers, most recently on the application of genomic analysis to understanding and optimizing treatment for these diseases.
Connors is best known for his clinical investigations into the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemias and multiple myeloma. Connors has published over peer-reviewed scientific articles addressing various aspects of research into lymphoid cancers. Mary Gospodarowicz. She holds specialty certifications in internal medicine, radiation oncology, and medical oncology and her clinical practice involves lymphomas and genitourinary cancers. Her research focused on clinical trials evaluating radiation therapy, image-guided precision radiotherapy, and cancer survivorship.
Her current interests include global cancer control, global access to radiotherapy, and quality cancer care. Warwick Prize for outstanding achievements in cancer control research from the Canadian Cancer Society. A tool which facilitates avoiding under treatment of fit elderly and over treatment of frail patients is needed.
In this book preoperative health status of the elderly undergoing major cancer surgery has been tested using comprehensive geriatric assessment CGA. First time ever, association of postoperative outcome with preoperative functional health is tested using CGA among the elderly undergoing major cancer surgery. Reed and R. I was looking at Mrs T — all 45 kilos of her — with somewhat puzzled thoughts. I had prescribed her capecitabine at very prudent doses, in view of her year-old kidneys and physiology.
- ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
- Revenge of the Middle-Aged Woman.
- Power without Persuasion: The Politics of Direct Presidential Action.
Her pain was improving and her chest mass was shrinking, as were her lung metastases… What was the secret of that response? Was her sarcopenia altering drug distribution? Was she absorbing more drug than average?
Browse by All Cardiff Authors
Or was her tumor exquisitely sensitive to fluoropyrimidines? Yet, there are fields where quite a lot remains to be learned. That ought to let us wonder how relevant data acquired in patients in their 60s are to a nonagenarian. Fortunately, geriatric oncologists have been stepping up to the task and have gen- ated data to help us to treat such patients. Authors: A. Balducci H.
Intended for medical oncologists and health care professionals involved in managing older patients with cancer, this book presents recent developments in geriatric assessment and in cancer management for the older adult. Anyone who is diagnosed with cancer receives a frightening blow, and in many cases the diagnosis is accompanied by a bewildering array of treatment choices. In this invaluable book, Dr. Richard C. Frank offers comfort and help to cancer patients, their families, and their caretakers.
Frank empowers patients by unlocking the mysteries of the disease and explaining in plain language the ways to confront and combat it. An award-winning medical oncologist recognized for his humanitarian approach as well as his research accomplishments, Dr. Frank understands that cancer patients and their families need insight into the disease along with a sense of control.
He therefore addresses these vital topics: what cancer is and how it spreads; how cancer treatment strategies are chosen; how cancer-fighting drugs work to shut down the growth of the disease; which factors affect a patient's prognosis; how patients can visualize cancer treatments at work in the body and why this is helpful; and, how to deal with 'uncurable' cancer.
With a wealth of patient case histories, helpful coping strategies from cancer survivors, and up-to-date information on useful resources, "Fighting Cancer" is a book cancer patients and their loved ones can turn to with confidence and hope. Anemia in the elderly, known as the silent epidemic, afflicts 3 million people in the U.